NEOG Stock Gains Following the Launch of Its New MDA2QSAL96 Kit

Company Developments - Neogen Corporation (NEOG) launched its new Neogen Molecular Detection Assay 2 – Quantitative Salmonella (MDA2QSAL96), which improves sensitivity and accuracy while providing an easy-to-use workflow [1] - The MDA2QSAL96 kit is part of Neogen's Molecular Detection System pathogen testing platform, which includes various next-generation assays for detecting pathogens [6][7] - The new assay allows poultry producers to verify the effectiveness of their interventions through a quantitative method that delivers excellent consistency and sensitivity [5] Market Performance - Following the announcement of the new assay, NEOG shares increased by 2.1% to $11.60 [2] - Neogen has a current market capitalization of$2.52 billion, with a Zacks Consensus Estimate for fiscal 2025 revenues at $935.1 million, indicating a 1.2$5.65 billion in 2024 and is projected to reach $8.78 billion by 2029, growing at a compound annual growth rate of 9.2% [9] - Technological advancements in microbiology testing and the rising incidence of fungal infections are driving market growth [9] Recent Innovations - Earlier in fiscal 2024, Neogen launched the Molecular Detection Assay 2 – Salmonella Enteritidis/Salmonella Typhimurium (MDA2SEST) and CelluSmart technology, further enhancing its offerings in the food safety segment [3] - In December 2024, Neogen introduced the Petrifilm Bacillus cereus Count Plate, adding to its Petrifilm product line for food safety testing [10]